Sort
78,016 grants matching “breast cancer”
ELASTOGRAPHY: CLINICAL AND BASIC SCIENCE
$1,411,402University Of Texas Hlth Sci Ctr Houston · P01 · FY2003 · EB
Cellular Interactions with Thrombospondin
$1,411,277David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Algorithmic approaches to systems biology, data integration, and evolution
$1,411,012Teresa Przytycka · National Library Of Medicine · ZIA · FY2023 · LM
NATIONAL BLACK LEADERSHIP INITIATIVE ON CANCER II: NETWO
$1,409,849Morehouse School Of Medicine · U01 · FY2001 · CA
NYU Center for the Study of Asian American Health
$1,409,742Chau Trinh-Shevrin · New York University School Of Medicine · P60 · FY2012 · MD
Molecular Imaging of Cancer and Its Response to Therapy
$1,409,387Kenneth A. Krohn · University Of Washington · P01 · FY2011 · CA
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI
$1,409,282Kaiser Foundation Research Institute · N01 · FY2000 · WH
Risk and penetrance of mutations from breast cancer testing panels.
$1,408,225Fergus Joseph Couch · Mayo Clinic Rochester · R01 · FY2014 · CA
Washington University/Siteman Cancer Center Lead Academic Site
$1,407,055Nancy L Bartlett · Washington University · UG1 · FY2021 · CA
Novel Targets in Cancer Chemotherapy: Chemical Biology of Guanine Alkylation
$1,406,557Michael P Stone · Vanderbilt University · P01 · FY2022 · CA
Determining and targeting mechanisms controlling cancer cell division
$1,406,377Jan M Skotheim · Stanford University · P01 · FY2023 · CA
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,406,073Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Howard/Hopkins Cancer Center Partnership
$1,405,818Howard University · U54 · FY2004 · CA
Genome-wide hypermutation and structural instability
$1,405,058William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
TRANSFORMING TRIPLE-NEGATIVE BREAST CANCER TREATMENT THROUGH INTRATUMORAL IMMUNOTHERAPY VIA NANOFLUIDIC DRUG-ELUTING SEED
$1,404,919The Methodist Hospital Research Institute · · FY2020 · Defense Health Agency
Enhancing Native American Participation in RT Trials
$1,404,486Rapid City Regional Hospital · U56 · FY2002 · CA
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,403,852Matthew J Ellis · Baylor College Of Medicine · U01 · FY2020 · CA
Nanotechnology Linking Biomarkers with Cancer Behavior
$1,403,458Shuming Nie · Emory University · R01 · FY2006 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$1,403,292Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$1,403,224David John Hunter · Brigham And Women'S Hospital · U01 · FY2009 · CA
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,402,983Gisela Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Nanotechnology Linking Biomarkers with Cancer Behavior
$1,402,782Emory University · R01 · FY2005 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,402,654Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
CHEROKEE NATION BREAST & CERVICAL CANCER EARLY DETECTION
$1,402,418Angela Leach · Cherokee Nation · U58 · FY2007 · DP
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$1,400,911James D Bearden · Spartanburg Regional Medical Center · U10 · FY2011 · CA